Background: Patients with obstructive sleep apnea syndrome (OSAS) are subject to an
increased cardiovascular morbidity including systemic hypertension. Little is known about …

Previous studies showed that treatment of obstructive sleep apnea syndrome (OSAS) with
continuous positive airway pressure (CPAP) significantly reduced the blood pressure (BP) in …

Background—There is increasing evidence that obstructive sleep apnea (OSA) is an
independent risk factor for arterial hypertension. Because there are no controlled studies …

Background Obstructive sleep apnea syndrome (OSAS) is an independent risk factor for
arterial hypertension. Several controlled trials have investigated the effect of continuous …

Objective: Several studies have reported a small yet significant decrease in blood pressure
(BP) with continuous positive airway pressure (CPAP) application in patients with obstructive …

Daytime blood pressure (BP) in 31 male patients with obstructive sleep apnea syndrome
(OSAS) wasmeasured and the effects of nasal continuous positive airway pressure (CPAP) …

Objectives Effective treatment of obstructive sleep apnoea (OSA) with nasal continuous
positive airway pressure (nCPAP) lowers blood pressure (BP). The long-term effects of …

Rationale: Continuous positive airway pressure (CPAP) is the current treatment for patients
with symptomatic obstructive sleep apnea (OSA). Its use for all subjects with sleep …

Objectives Previous reports on the effects of continuous positive airway pressure (CPAP)
therapy for obstructive sleep apnoea (OSA) on blood pressure has shown contradictory …

Background: Patients with obstructive sleep apnea (OSA) are at increased risk for
hypertension. The mechanisms responsible for the development of hypertension are …